摘要
分子检测在血液肿瘤诊断分型、预后判断、药物疗效预测、微小残留病监测中具有日益重要的应用价值。目前我国一些临床实验室正在开展血液肿瘤相关的分子检测。在临床检测需求日益增长的情况下,应当重视血液肿瘤相关分子检测实验室人员队伍的建设,其中具备临床医学知识的实验室试剂与方法研发人员和实验室质量管理人员的培养是现阶段迫切需要解决的关键问题。
There has consistently growing value of molecular detection to deliver clinical results for diagnosis,classification,prognosis,curative effect prediction and monitoring minimal residual disease of hematological neoplasms.Currently,some clinical laboratories are adopting hematological neoplasms-associated molecular detection in in our country.The increasing demands for clinical testing require that the particular attention need to be paid to the building of the team of professional staff.At present,it is vital to cultivate two kinds of specialized personnel:the technical personnel who are educated in clinical medicine and skilled in developing molecular tests;and the trained managers who are adept at quality control for molecular testing.
作者
张瑞
吴祁生
李金明
Zhang Rui;Wu Qisheng;Li Jinming(National Center for Clinical Laboratories,Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing 100730,China;Division of Pathology and Laboratory Medicine,Beijing Ludaopei Hospital,Beijing 100176,China)
出处
《中华医学杂志》
CAS
CSCD
北大核心
2021年第13期904-907,共4页
National Medical Journal of China
关键词
血液肿瘤
基因
突变
分子诊断技术
Hematologic neoplasms
Genes
Mutation
Molecular diagnostic techniques